Unlikely allies MSD, Cipla link to co-market Isentress in India

MSD (as Merck & Co is known outside the US and Canada) and Cipla, never really considered natural allies, have now formed an India-specific partnership, under which Cipla will co-market the US firm's HIV drug Isentress (raltegravir).